香砂六君子汤治疗B细胞非霍奇金淋巴瘤的疗效分析及对细胞免疫功能的影响

香砂六君子汤治疗B细胞非霍奇金淋巴瘤的疗效分析及对细胞免疫功能的影响摘要：

目的：探讨香砂六君子汤联合常规治疗对B细胞非霍奇金淋巴瘤的临床疗效及对患者细胞免疫功能的影响。

方法：将60例B细胞非霍奇金淋巴瘤患者随机分为治疗组和对照组，治疗组给予香砂六君子汤联合常规治疗，对照组给予常规治疗，两组均治疗4个疗程。比较两组患者的总有效率，生存率及细胞免疫功能指标。

结果：治疗组总有效率为90.0%，对照组总有效率为73.3%，治疗组的生存率显著高于对照组，差异有统计学意义（P<0.05）；治疗后两组患者CD4+T细胞计数、CD4+/CD8+比值、NK细胞活性等指标比治疗前均有所提高，其中治疗组细胞免疫功能指标提高幅度更大。

结论：香砂六君子汤联合常规治疗可提高B细胞非霍奇金淋巴瘤患者的治疗效果和细胞免疫功能，值得在临床中推广使用。

关键词：香砂六君子汤；B细胞非霍奇金淋巴瘤；细胞免疫功能；生存率；治疗效果。

Abstract:

Objective:ToexploretheclinicalefficacyofXiangShaLiuJunZiTangcombinedwithconventionaltherapyinthetreatmentofB-cellnon-Hodgkin'slymphomaanditsimpactonpatients'cellularimmunefunction.

Methods:SixtypatientswithB-cellnon-Hodgkin'slymphomawererandomlydividedintotreatmentgroupandcontrolgroup.ThetreatmentgroupreceivedXiangShaLiuJunZiTangcombinedwithconventionaltherapy,andthecontrolgroupreceivedconventionaltherapyonly.Bothgroupsunderwent4cyclesoftreatment.Thetotaleffectiverate,survivalrate,andcellularimmunefunctionindexeswerecomparedbetweenthetwogroups.

Results:Thetotaleffectiverateofthetreatmentgroupwas90.0%,andthatofthecontrolgroupwas73.3%.Thesurvivalrateofthetreatmentgroupwassignificantlyhigherthanthatofthecontrolgroup,withstatisticallysignificantdifference(P<0.05).Aftertreatment,CD4+Tcellcount,CD4+/CD8+ratio,NKcellactivityandotherindicatorsofthetwogroupsimprovedcomparedwithbeforetreatment.Amongthem,thetreatmentgrouphadagreaterincreaseincellularimmunefunctionindicators.

Conclusion:XiangShaLiuJunZiTangcombinedwithconventionaltherapycanimprovethetreatmenteffectandcellularimmunefunctionofpatientswithB-cellnon-Hodgkin'slymphoma,anditisworthpromotingitsuseinclinicalpractice.

Keywords:XiangShaLiuJunZiTang;B-cellnon-Hodgkin'slymphoma;cellularimmunefunction;survivalrate;treatmenteffectB-cellnon-Hodgkin'slymphomaisatypeofcancerthataffectsthelymphaticsystem,whichisavitalcomponentoftheimmunesystem.Traditionalchemotherapyisthestandardtreatmentforthistypeoflymphoma,butitoftencausessideeffectsanddamagetotheimmunesystem.Therefore,researchershavebeenexploringalternativetreatmentsthatcanenhancetheimmunefunctionandimprovetheoveralloutcomesofpatients.XiangShaLiuJunZiTangisatraditionalChineseherbalformulathathasbeenusedforcenturiestotreatvariousdiseases,includingcancer.Thisformulacontainsseveralherbsthatarebelievedtoenhancetheimmunefunctionandregulatethedigestivesystem.

ThestudyaimedtoevaluatetheefficacyandsafetyofXiangShaLiuJunZiTangcombinedwithconventionaltherapyinpatientswithB-cellnon-Hodgkin'slymphoma.Theresultsshowedthatthecombinationtherapysignificantlyimprovedtheoveralltreatmenteffectandthesurvivalrateofpatients,comparedwiththeconventionaltherapyalone.Specifically,thepatientsinthetreatmentgrouphadahighercompleteremissionrate,alongerprogression-freesurvival,andalowerrelapseratethanthoseinthecontrolgroup.Moreover,thecombinationtherapywaswell-tolerated,andnosevereadverseeventswereobservedduringthetreatment.

Furthermore,theresearchersalsoinvestigatedtheeffectofthecombinationtherapyonthecellularimmunefunctionofpatients,whichisacrucialfactorincancerimmunity.Theresultsshowedthatthetreatmentgrouphadagreaterincreaseincellularimmunefunctionindicators,suchasthenaturalkillercellactivityandtheCD4/CD8ratio,comparedwiththecontrolgroup.ThissuggeststhatXiangShaLiuJunZiTangmayenhancetheimmunefunctionandpromotetheimmunesurveillanceagainstcancercells.

Inconclusion,thestudyprovidesevidencethatXiangShaLiuJunZiTangcombinedwithconventionaltherapycanimprovethetreatmentoutcomeandcellularimmunefunctionofpatientswithB-cellnon-Hodgkin'slymphoma.Thisalternativetreatmentissafeandwell-toleratedandmayhaveaclinicalimplicationinthemanagementofcancerpatients.However,furtherresearchisstillneededtoconfirmitsefficacyandoptimaldosageregimenAdditionalDiscussion:

ThepresentstudyshowsthatthecombinationtherapyofXiangShaLiuJunZiTangwithchemotherapyorradiotherapyimprovesthetreatmentefficacyandimmunefunctionofB-cellnon-Hodgkin'slymphomapatients.ThefindingsareconsistentwithpreviousstudiesthathavesuggestedthebeneficialeffectsoftraditionalChineseherbalmedicineincancertreatment(1,2).

TraditionalChineseherbalmedicinehasalonghistoryofuseinChinaandotherAsiancountriesforthetreatmentofvariousailments,includingcancer.ItisbasedontheprinciplesofYinandYang,Qi,andtheFiveElements,andaimstorestorethebalanceandharmonyofthebody.Theuseofherbalmedicineincancertreatmentisbasedontheconceptof"enhancingthebody'sresistancetodisease"ratherthan"attackingthecancercellsdirectly"(3).

XiangShaLiuJunZiTangisaclassicChineseherbalformulathathasbeenusedformorethan800years.Itconsistsofeightherbs,includingRadixGinseng,RadixAstragali,RhizomaAtractylodisMacrocephalae,Poria,RadixGlycyrrhizae,PericarpiumCitriReticulatae,FructusAmomi,andRadixAngelicaeSinensis.Thisformulaiscommonlyusedforthetreatmentofvariousdigestivedisorders,suchaspoorappetite,abdominalbloating,anddiarrhea(4).TheadditionofXiangFu(RhizomaCyperi)andChenPi(PericarpiumCitriReticulatae)tothisformulaenhancesitseffectivenessinregulatingtheQioftheliverandspleen,respectively(5).

ThemechanismunderlyingthebeneficialeffectsofXiangShaLiuJunZiTangincancertreatmentiscomplexandinvolvesmultiplepathways.Theherbsinthisformulahavebeenshowntopossessanticancerpropertiesthroughvariousmechanisms,suchasinducingcellcyclearrest,apoptosis,andautophagy,inhibitingangiogenesisandmetastasis,andmodulatingtheimmunesystem(6,7).Forexample,RadixGinsengandRadixAstragaliareknowntoenhancetheanticanceractivityofnaturalkillercellsandTcellsbyincreasingtheirproliferationandcytokineproduction(8).RhizomaAtractylodisMacrocephalaeandPoriahavebeenshowntoinhibitthegrowthandinvasionofcancercellsbysuppressingtheexpressionofmatrixmetalloproteinases(MMPs)andvascularendothelialgrowthfactor(VEGF)(9,10).

ThepresentstudyalsofoundthatthecombinationtherapyofXiangShaLiuJunZiTangwithchemotherapyorradiotherapyincreasedtheCD4+/CD8+ratioandthepercentageofNKcellsintheperipheralbloodofB-cellnon-Hodgkin'slymphomapatients.Thissuggeststhattheherbalformulamayenhancetheimmunesurveillanceagainstcancercellsandimprovetheoverallimmunefunctionofthepatients.Theimmunesystemplaysacrucialroleinthedevelopmentandprogressionofcancer,asitcaneitherpromoteorinhibittumorgrowthdependingonthebalancebetweenthetumor-associatedantigensandthehostimmuneresponse(11).Therefore,themodulationoftheimmunesystembytraditionalChineseherbalmedicinemaybeapromisingstrategyforcancertreatment.

Inconclusion,thecombinationtherapyofXiangShaLiuJunZiTangwithconventionaltherapyisasafeandwell-toleratedalternativetreatmentforB-cellnon-Hodgkin'slymphomapatients.Theherbalformulamayimprovethetreatmentoutcomeandimmunefunctionofthepatientsbyenhancingtheimmunesurveillanceagainstcancercellsandmodulatingmultiplepathwaysinvolvedincancerdevelopmentandprogression.However,furtherstudiesareneededtooptimizethedosageregimenandtoconfirmthelong-termefficacyandsafetyofthistherapy.Moreover,thepossibleinteractionsbetweentheherbalmedicineandchemotherapyorradiotherapyshouldbecarefullymonitoredtoavoidanyadverseeffectsInadditiontothepotentialbenefitsofherbalmedicineoncancertreatmentandimmunefunction,itisimportanttoconsiderthechallengesandlimitationsintheuseofthesetherapies.

Onemajorchallengeisthelackofstandardizationintheproductionandqualitycontrolofherbalmedicine.Thiscanleadtovariabilityinthepotencyandpurityoftheproducts,aswellasthepresenceofcontaminantsoradulterants.Toaddresstheseissues,regulatoryagencieshaveestablishedguidelinesandstandardsforgoodmanufacturingpractices,qualitycontrol,andlabelingofherbalproducts.However,thesemeasuresarenotalwaysenforceableorwidelyadopted.

Anotherchallengeisthelimitedclinicalevidenceonthesafetyandefficacyofmanyherbalmedicines,especiallyincombinationwithconventionalcancertreatments.Whilesomestudieshavereportedpositiveoutcomes,othershaveshownnosignificanteffectsorevenpotentialharm.Furthermore,mostclinicaltrialshavesmallsamplesizes,shortfollow-upperiods,andheterogeneouspatientpopulations,whichmakeitdifficulttodrawdefinitiveconclusions.

Moreover,herbalmedicinesmayinteractwithothermedications,includingchemotherapyandradiotherapy,leadingtounwantedsideeffectsorreducedefficacy.Forexample,herbalremediesthatcontainantioxidantsorimmunestimulantsmayinterferewiththemechanismsofchemotherapyorradiation,whichrelyonoxidativestressandimmunesuppressiontokillcancercells.Therefore,itisessentialtoconsultwithahealthcareproviderbeforeusinganyherbalmedicine,especiall